BACKGROUND AND PURPOSE: Unrecognized or unreported stroke-like symptoms, called covert symptoms, occur in persons free of clinical stroke. Whether covert symptoms are associated with subclinical brain infarcts (SBIs) is unknown. This study examined the association between covert stroke-like symptoms and SBI/stroke in persons with no history of stroke or transient ischemic attack. METHODS: A total of 1881 Atherosclerosis Risk in Communities (ARIC) participants free of clinical stroke or transient ischemic attack (40% male, 50% black, 47-70 years) were queried for covert symptoms and underwent cerebral MRI during the baseline MRI visit. Symptoms were reassessed after 3 years at Visit 4 (n=1001; 39% male, 50% black) and approximately 10 years with a follow-up MRI (n=1006; 40% male, 50% black, 61-83 years). RESULTS: Covert symptoms were associated with prevalent SBI (OR, 1.94; 95% CI, 1.21-3.11; P=0.006). No support was found for associations between baseline MRI symptoms and SBI at the follow up MRI visit. In participants without SBI at baseline, symptoms at Visit 4 (OR, 2.96; 1.23-7.13; P=0.016) and symptoms at the follow-up MRI visit (OR, 4.29; 2.51-7.33; P<0.001) were associated with a combined outcome of new SBI/clinical stroke on follow-up MRI. Covert symptoms at follow-up MRI visit were also associated with having new SBI (OR, 2.26; 1.18-4.32; P=0.014) on the follow-up MRI that were not seen on the baseline MRI. CONCLUSIONS: Covert neurological symptoms were associated with prevalent SBI, and when ascertained at the time of follow-up MRI, with new SBI. Covert symptoms may reflect heightened risk for infarcts.
BACKGROUND AND PURPOSE: Unrecognized or unreported stroke-like symptoms, called covert symptoms, occur in persons free of clinical stroke. Whether covert symptoms are associated with subclinical brain infarcts (SBIs) is unknown. This study examined the association between covert stroke-like symptoms and SBI/stroke in persons with no history of stroke or transient ischemic attack. METHODS: A total of 1881 Atherosclerosis Risk in Communities (ARIC) participants free of clinical stroke or transient ischemic attack (40% male, 50% black, 47-70 years) were queried for covert symptoms and underwent cerebral MRI during the baseline MRI visit. Symptoms were reassessed after 3 years at Visit 4 (n=1001; 39% male, 50% black) and approximately 10 years with a follow-up MRI (n=1006; 40% male, 50% black, 61-83 years). RESULTS: Covert symptoms were associated with prevalent SBI (OR, 1.94; 95% CI, 1.21-3.11; P=0.006). No support was found for associations between baseline MRI symptoms and SBI at the follow up MRI visit. In participants without SBI at baseline, symptoms at Visit 4 (OR, 2.96; 1.23-7.13; P=0.016) and symptoms at the follow-up MRI visit (OR, 4.29; 2.51-7.33; P<0.001) were associated with a combined outcome of new SBI/clinical stroke on follow-up MRI. Covert symptoms at follow-up MRI visit were also associated with having new SBI (OR, 2.26; 1.18-4.32; P=0.014) on the follow-up MRI that were not seen on the baseline MRI. CONCLUSIONS: Covert neurological symptoms were associated with prevalent SBI, and when ascertained at the time of follow-up MRI, with new SBI. Covert symptoms may reflect heightened risk for infarcts.
Authors: Catherine L Carey; Joel H Kramer; S Andrew Josephson; Dan Mungas; Bruce R Reed; Norbert Schuff; Michael W Weiner; Helena C Chui Journal: Stroke Date: 2007-12-20 Impact factor: 7.914
Authors: L E Chambless; E Shahar; A R Sharrett; G Heiss; L Wijnberg; C C Paton; P Sorlie; J F Toole Journal: Am J Epidemiol Date: 1996-11-01 Impact factor: 4.897
Authors: R N Bryan; T A Manolio; L D Schertz; C Jungreis; V C Poirier; A D Elster; R A Kronmal Journal: AJNR Am J Neuroradiol Date: 1994-10 Impact factor: 3.825
Authors: W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar Journal: Stroke Date: 1999-04 Impact factor: 7.914
Authors: R N Bryan; J Cai; G Burke; R G Hutchinson; D Liao; J F Toole; A P Dagher; L Cooper Journal: AJNR Am J Neuroradiol Date: 1999-08 Impact factor: 3.825
Authors: Virginia G Wadley; Leslie A McClure; Virginia J Howard; Frederick W Unverzagt; Rodney C Go; Claudia S Moy; Martha R Crowther; Camilo R Gomez; George Howard Journal: Stroke Date: 2007-02-22 Impact factor: 7.914
Authors: Gabriel Gold; Enikö Kövari; François R Herrmann; Alessandra Canuto; Patrick R Hof; Jean-Pierre Michel; Constantin Bouras; Panteleimon Giannakopoulos Journal: Stroke Date: 2005-05-12 Impact factor: 7.914
Authors: Andrew Laflam; Brijen Joshi; Kenneth Brady; Gayane Yenokyan; Charles Brown; Allen Everett; Ola Selnes; Edward McFarland; Charles W Hogue Journal: Anesth Analg Date: 2015-01 Impact factor: 5.108
Authors: Catherine Arnold Fiebelkorn; Prashanthi Vemuri; Alejandro A Rabinstein; Michelle M Mielke; Scott A Przybelski; Kejal Kantarci; David T Jones; Robert D Brown; David S Knopman; Ronald C Petersen; Clifford R Jack; Jonathan Graff-Radford Journal: Mayo Clin Proc Date: 2018-02-14 Impact factor: 7.616
Authors: Erin D Michos; Kathryn A Carson; Andrea L C Schneider; Pamela L Lutsey; Li Xing; A Richey Sharrett; Alvaro Alonso; Laura H Coker; Myron Gross; Wendy Post; Thomas H Mosley; Rebecca F Gottesman Journal: JAMA Neurol Date: 2014-07-01 Impact factor: 18.302
Authors: K K Landry; K S Alexander; N A Zakai; S E Judd; D O Kleindorfer; V J Howard; G Howard; M Cushman Journal: J Thromb Haemost Date: 2016-12-09 Impact factor: 5.824
Authors: Clinton B Wright; Nirav H Shah; Armando J Mendez; Janet T DeRosa; Mitsuhiro Yoshita; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Tatjana Rundek; Shonni Silverberg; Chuanhui Dong; Myles Wolf Journal: Stroke Date: 2016-03-08 Impact factor: 7.914
Authors: Virginia J Howard; Monika M Safford; Shauntice Allen; Suzanne E Judd; J David Rhodes; Dawn O Kleindorfer; Elsayed Z Soliman; James F Meschia; George Howard Journal: J Stroke Cerebrovasc Dis Date: 2016-01-08 Impact factor: 2.136
Authors: Bernhard Haring; Adam Omidpanah; Astrid M Suchy-Dicey; Lyle G Best; Steven P Verney; Dean K Shibata; Shelley A Cole; Tauqeer Ali; Barbara V Howard; Dedra Buchwald; Richard B Devereux Journal: Hypertension Date: 2017-09-11 Impact factor: 10.190